Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First-in-human trial supports benefits of BKT-140 in autologous transplantation for multiple myeloma

Dec. 10, 2010

CUDC-101 shows good tolerability in first-in-human trial in advanced solid tumors

Dec. 10, 2010

Development of cancer stem cell-targeting agents SL-401 and SL-501 continues

Dec. 10, 2010

Enrollment complete in phase III trial of subcutaneous Herceptin in HER2+ breast cancer

Dec. 10, 2010

ArQule evaluates ARQ-087 in models of cancer

Dec. 9, 2010

Lilly divulges new vinyl indazolyl agents with antitumor activity

Dec. 9, 2010

ArQule begins phase I trial of ARQ-736 in advanced solid tumors

Dec. 9, 2010

ACT Biotech describes unique mechanism of action of ACTB-1003

Dec. 9, 2010

BI-6727 shows promise in phase I/II trial in acute myeloid leukemia

Dec. 9, 2010

Phase I/II data presented on MLN-8237 in hematological malignancies

Dec. 9, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...